SCHEMBL4221905

SCHEMBL4221905

CC(=O)NC1=CCC2CCC=CC2=C1

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5960697 0.67 SMN1; SMN2 (0.34) NAMPT
SCHEMBL13715702 0.65
SCHEMBL12992825 0.64
SCHEMBL7874522 0.64 HSP90AA1 (0.33) NAMPT
SCHEMBL17733547 0.63 NAMPT (0.33) NAMPT
SCHEMBL17733614 0.63 L3MBTL1 (0.33) NAMPT
SCHEMBL17733595 0.62 NAMPT (0.33) NAMPT
SCHEMBL20342898 0.62 NAMPT (0.33) NAMPT
SCHEMBL22312264 0.62 TDP1 (0.33)
SCHEMBL13591827 0.62 HSP90AA1 (0.33) NAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009124086-A2 ANTIBACTERIAL DRUG FOR TREATMENT OF STAPHYLOCOCCUS AUREUS AND OTHER GRAM-POSITIVE BACTERIAL INFECTIONS SIGA TECHNOLOGIES, INC. (US) 2009-10-08 WO claimed
WO-2009124086-A2 ANTIBACTERIAL DRUG FOR TREATMENT OF STAPHYLOCOCCUS AUREUS AND OTHER GRAM-POSITIVE BACTERIAL INFECTIONS SIGA TECHNOLOGIES, INC. (US) 2009-10-08 WO disclosed